Beverly G Tchang,Sarah Barenbaum,Louis J Aronne
Beverly G Tchang
Early electronic specialist-led diabetes care improves post-discharge glycaemia: the STOIC-D Surgery follow-up cohort [0.03%]
早期电子专家糖尿病护理改善术后出院患者的血糖控制：STOIC-D手术随访队列研究
Isuru L Gamage,Rahul D Barmanray,Mervyn Kyi et al.
Isuru L Gamage et al.
Objective: To assess the effect of an early, electronic specialist-led model of inpatient diabetes care on glycaemic outcomes following discharge and rates of treatment intensification. ...
Letter to the Editor from Hasebe and Su: "Diabetes Progression and Its Impact on Kidney Cancer Risk: Insights From a Longitudinal Korean Cohort Study" [0.03%]
我刊发表的Hasebe和Su来信的编辑部回应：“糖尿病进展及其对肾癌风险的影响：来自韩国纵向队列研究的新见解”
Masashi Hasebe,Chen-Yang Su
Masashi Hasebe
Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease [0.03%]
减量策略在甲亢停药后复发中的作用研究
Keitaro Miyamura,Mitsuru Ito,Hiroyuki Yamaoka et al.
Keitaro Miyamura et al.
Background: Although antithyroid drugs (ATDs) are widely used as the first-line therapy for Graves' disease, relapse after treatment discontinuation remains common. While a prolonged low-dose ATD therapy has been associat...
Children with diabetes and at least one non-autoimmune feature should be considered for monogenic diabetes testing [0.03%]
糖尿病伴至少一个非自身免疫特征的患儿应考虑单基因糖尿病筛查
Rebecca Myers,Melek Yildiz,Mehmet Nuri Ozbek et al.
Rebecca Myers et al.
Aims: Monogenic diabetes testing in children currently targets Maturity Onset Diabetes in the Young (MODY) or recognised genetic syndromes. We aim to determine whether genetic testing for monogenic diabetes should be perf...
Hirotaka Watada
Hirotaka Watada
The time of the hypertonic saline infusion test for the diagnosis of AVP deficiency can be shortened with LC-MS/MS [0.03%]
应用液相色谱串联质谱法可以缩短高渗盐水兴奋试验诊断精氨酸加压素缺乏的时间
Tomoko Handa,Daisuke Hagiwara,Ryutaro Maeda et al.
Tomoko Handa et al.
Context: In clinical practice, plasma arginine vasopressin (AVP) concentrations have been measured with a radioimmunoassay (RIA). However, RIAs have limitations, such as long turnaround time, use of radioisotopes, and res...
Predicting long-term outcomes in Cushing's disease: so close and yet so far [0.03%]
库欣病长期转归的预测：如此接近而又如此遥远
Marily Theodoropoulou,Martin Reincke
Marily Theodoropoulou
Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trial [0.03%]
托伐普坦与液体限制在中重度低钠血症治疗中的疗效对比：一项开放标签随机临床试验
Annabelle M Warren,Mathis Grossmann,Rudolf Hoermann et al.
Annabelle M Warren et al.
Context: Current first-line therapy for hyponatremia, fluid restriction (FR), is often unsuccessful. Tolvaptan, an arginine vasopressin V2-receptor antagonist, is effective however concerns about plasma sodium (pNa) overc...